Mark Lesselroth, CEO of BioPortUSA will speak at the BIO International Convention June 3-6 in Philadelphia, PA. on the subject of “Demystifying Market Entry into the USA” The focus of this presentation will be on providing an overview of what it takes for an international life science company to effectively enter the US market and accelerate the commercialization of their product lines. We will touch on the importances of determining early investment, IP Landscape, Regulatory Pathway, and the importance of Market Access. The latter is perhaps the most critical as it is an area that most international companies have little experience with but will need to understand if they are going to achieve success in the USA.
The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. It is expected to bring over 16,000 attendees from 74 countries around the world.
Learn more about BIO International Convention here.